Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$13.6 million.

  • Lifecore Biomedical's Free Cash Flow fell 45.86% to $3.2 million in Q2 2025 from the same period last year, while for May 2025 it was -$13.6 million, marking a year-over-year increase of 24.90%. This contributed to the annual value of -$13.6 million for FY2025, which is 24.90% up from last year.
  • As of FY2025, Lifecore Biomedical's Free Cash Flow stood at -$13.6 million, which was up 24.90% from -$18.1 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Free Cash Flow high stood at -$8.8 million for FY2021, and its period low was -$52.5 million during FY2022.
  • In the last 3 years, Lifecore Biomedical's Free Cash Flow had a median value of -$18.1 million in 2024 and averaged -$23.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 79.98% in 2021, then slumped by 500.24% in 2022.
  • Lifecore Biomedical's Free Cash Flow (Yearly) stood at -$8.8 million in 2021, then plummeted by 500.24% to -$52.5 million in 2022, then rose by 25.91% to -$38.9 million in 2023, then spiked by 53.40% to -$18.1 million in 2024, then grew by 24.90% to -$13.6 million in 2025.